Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rxo (RXO) Equity Average (2021 - 2025)

Rxo's Equity Average history spans 5 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Equity Average fell 4.38% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 4.38%, while the annual FY2025 figure was $1.6 billion, 42.93% up from the prior year.
  • Equity Average reached $1.6 billion in Q4 2025 per RXO's latest filing, down from $1.6 billion in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.6 billion in Q4 2024 to a low of $580.5 million in Q2 2024.
  • Average Equity Average over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2021.
  • Peak YoY movement for Equity Average: tumbled 49.68% in 2023, then surged 175.68% in 2024.
  • A 5-year view of Equity Average shows it stood at $1.1 billion in 2021, then fell by 18.5% to $865.5 million in 2022, then tumbled by 31.6% to $592.0 million in 2023, then skyrocketed by 175.68% to $1.6 billion in 2024, then dropped by 4.38% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for RXO's Equity Average are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.6 billion (Q2 2025).